Effect of lithium and lithium withdrawal on potassium-evoked dopamine release and tyrosine hydroxylase expression in the rat

International Journal of Neuropsychopharmacology

Volumn 9, Issue 6, 2006, Pages 729-735

  Ferrie, Lindsey ^a   Young, Allan H ^a   McQuade, Richard ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Dopamine; In vivo microdialysis; Lithium; Lithium withdrawal; Nucleus accumbens

Indexed keywords

DOPAMINE; LITHIUM CHLORIDE; MESSENGER RNA; POTASSIUM; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET; DOPAMINE RELEASE; DRUG EFFECT; DRUG WITHDRAWAL; HISTOCHEMISTRY; IN SITU HYBRIDIZATION; IN VIVO STUDY; MALE; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; THALAMUS VENTRAL NUCLEUS;

ANIMALS; ANTIMANIC AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIET; DOPAMINE; ELECTROCHEMISTRY; IN SITU HYBRIDIZATION; LITHIUM; LITHIUM CARBONATE; MALE; MICRODIALYSIS; NUCLEUS ACCUMBENS; OLIGONUCLEOTIDE PROBES; POTASSIUM; RATS; RNA, MESSENGER; SUBSTANCE WITHDRAWAL SYNDROME; TYROSINE 3-MONOOXYGENASE;

EID: 33846334440     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145705006243     Document Type: Article

References (27)

1. Ahluwalia P, Singhal RL (1984). Comparison of the changes in central catecholamine systems following short- and long-term lithium treatment and the consequences of lithium withdrawal. Neuropsychobiology 12, 217-223.
2. Anand A, Verhoeff P, Seneca N, Zoghbi SS, Seibyl JP, Charney DS, Innis RB (2000). Brain SPECT imaging of amphetamine-induced dopamine release in euthymic bipolar disorder patients. American Journal of Psychiatry 157, 1108-1114.
3. Baptista T, Teneud L, Contreras Q, Burguera JL, Burguera M, Hernandez L (1993). Effects of acute and chronic lithium treatment on amphetamine-induced dopamine increase in the nucleus accumbens and prefrontal cortex in rats as studied by microdialysis. Journal of Neural Transmission (General Section) 94, 75-89.
4. Beaulieu JM, Sotnikova TD, Yao WD, Kockeritz L, Woodgett JR, Gainetdinov RR, Caron MG (2004). Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Proceedings of the National Academy of Sciences USA 101, 5099-5104.
5. Berggren U (1985). Effects of chronic lithium treatment on brain monoamine metabolism and amphetamine-induced locomotor stimulation in rats. Journal of Neural Transmission 64, 239-250.
6. Dziedzicka-Wasylewska M, Mackowiak M, Fijat K, Wedzony K (1996). Adaptive changes in the rat dopaminergic transmission following repeated lithium administration. Journal of Neural Transmission 103, 765-776.
7. Dziedzicka-Wasylewska M, Wedzony K (1996). The effect of prolonged administration of lithium on the level of dopamine D2 receptor mRNA in the rat striatum and nucleus accumbens. Acta Neurobiologiae Experimentalis (Warsz) 56, 29-34.
8. Ferrie L, Young AH, McQuade R (2005). Effect of chronic lithium and withdrawal from chronic lithium on presynaptic dopamine function in the rat. Journal of Psychopharmacology 19, 229-234.
9. Gambarana C, Ghiglieri O, Masi F, Scheggi S, Tagliamonte A, De Montis MG (1999). The effects of long-term administration of rubidium or lithium on reactivity to stress and on dopamine output in the nucleus accumbens in rats. Brain Research 826, 200-209.
10. Gelenberg AJ, Hopkins HS (1996). Antipsychotics in bipolar disorder. Journal of Clinical Psychiatry 57 (Suppl. 9), 49-52.
11. Goodwin GM (1994). Recurrence of mania after lithium withdrawal. Implications for the use of lithium in the treatment of bipolar affective disorder. British Journal of Psychiatry 164, 149-152.
12. Hjorth S, Bengtsson HJ, Kullberg A, Carlzon D, Peilot H, Auerbach SB (2000). Serotonin autoreceptor function and antidepressant drug action. Journal of Psychopharmacology 14, 177-185.
13. Hyland BI, Reynolds JN, Hay J, Perk CG, Miller R (2002). Firing modes of midbrain dopamine cells in the freely moving rat. Neuroscience 114, 475-492.
14. Klein E, Mairaz R, Pascal M, Hefez A, Lavie P (1991). Discontinuation of lithium treatment in remitted bipolar patients: relationship between clinical outcome and changes in sleep-wake cycles. Journal of Nervous and Mental Disease 179, 499-501.
15. Mander AJ, Loudon JB (1988). Rapid recurrence of mania following abrupt discontinuation of lithium. Lancet 2, 15-17.
16. Pania L, Gessab GL (2002). Dopaminergic deficit and mood disorders. International Clinical Psychopharmacology 17 (Suppl. 4), S1-S7; discussion S7.
17. Paxinos G, Watson C (1997). The Rat Brain in Stereotaxic Coordinates. London, UK: Academic Press.
18. Pei Q, Burnet PW, Grahame-Smith DG, Zetterstrom TS (1997). Differential effects of acute and chronic electroconvulsive shock on the abundance of messenger RNAs for voltage-dependent potassium channel subunits in the rat brain. Neuroscience 78, 343-350.
19. Pei Q, Leslie RA, Grahame-Smith DG, Zetterstrom TS (1995). 5-HT efflux from rat hippocampus in vivo produced by 4-aminopyridine is increased by chronic lithium administration. Neuroreport 6, 716-720.
20. Rastogi RB, Singhal RL (1977). Lithium suppresses elevated behavioural activity and brain catecholamines in developing hyperthyroid rats. Canadian Journal of Physiology and Pharmacology 55, 490-495.
21. Reches A, Jackson-Lewis V, Fahn S (1984). Lithium does not interact with haloperidol in the dopaminergic pathways of the rat brain. Psychopharmacology (Berlin) 82, 330-334.
22. Silverstone T (1985). Dopamine in manic depressive illness. A pharmacological synthesis. Journal of Affective Disorders 8, 225-231.
23. Suppes T, Baldessarini RJ, Faedda GL, Tohen M (1991). Risk of recurrence following discontinuation of lithium treatment in bipolar disorder. Archives of General Psychiatry 48, 1082-1088.
24. Tatsumi M, Groshan K, Blakely RD, Richelson E (1997). Pharmacological profile of antidepressants and related compounds at human monoamine transporters. European Journal of Pharmacology 340, 249-258.
25. Valentini V, Frau R, Di Chiara G (2004). Noradrenaline transporter blockers raise extracellular dopamine in medial prefrontal but not parietal and occipital cortex: differences with mianserin and clozapine. Journal of Neurochemistry 88, 917-927.
26. Wood AJ, Goodwin GM, De Souza R, Green AR (1986). The pharmacokinetic profile of lithium in rat and mouse; an important factor in psychopharmacological investigation of the drug. Neuropharmacology 25, 1285-1288.
27. Yatham LN, Liddle PF, Lam RW, Shiah IS, Lane C, Stoessl AJ, Sossi V, Ruth TJ (2002). PET study of the effects of valproate on dopamine D(2) receptors in neuroleptic- and mood-stabilizer-naive patients with nonpsychotic mania. American Journal of Psychiatry 159, 1718-1723.